News | August 25, 2024
BioIVT acquires ZenBio
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
Rad-Sure blood irradiation indicators are FDA 510 (k) cleared medical devices that offer positive visual verification of irradiation at the minimum specified dose
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
Revolutionary technology will further boost OneSource’s scientific services offerings
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept
Subscribe To Our Newsletter & Stay Updated
